Oestrogens and oestrogen receptors in prostate cancer

Article English OPEN
Kowalska, Karolina; Piastowska-Ciesielska, Agnieszka Wanda;
(2016)
  • Publisher: Springer Nature
  • Journal: SpringerPlus,volume 5 (issn: 2193-1801, eissn: 2193-1801)
  • Related identifiers: doi: 10.1186/s40064-016-2185-6, pmc: PMC4844569
  • Subject: Oestrogen | Prostate cancer | Review | Oestrogen receptor β | Oestrogen receptor α
    mesheuropmc: urologic and male genital diseases

The role of androgens in prostate cancer is obvious due to the fact that androgen signalling is the main regulator of prostate growth and function. Androgen deprivation therapy is a mainstay treatment for advanced prostate cancer. However, prostate cancer often becomes ... View more
  • References (63)
    63 references, page 1 of 7

    Bishop JL, Davies AH, Ketola K, Zoubeidi A (2015) Regulation of tumor cell plasticity by the androgen receptor in prostate cancer. Endocr Relat Cancer 22(3):R165-R182

    Brodin G, ten Dijke P, Funa K, Heldin CH, Landstrom M (1999) Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59:2731-2738

    Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, MacDonald TY, Fontugne J, Erho N, Vergara IA, Ghadessi M, Davicioni E, Jenkins RB, Palanisamy N, Chen Z, Nakagawa S, Hirose T, Bander NH, Beltran H, Fox AH, Elemento O, Rubin MA (2014) The oestrogen receptor alpha‑regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 5:5383

    Cheng J, Lee EJ, Madison LD, Lazennec G (2004) Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566:169-172

    Chipuk JE, Bhat M, Hsing AY, Ma J, Danielpour D (2001) Bcl‑xL blocks transforming growth factor‑beta 1‑induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf‑1‑ dependent caspase activation in prostate epithelial cells. J Biol Chem 276:26614-26621

    Christoforou P, Christopoulos PF, Koutsilieris M (2014) The role of estrogen receptor beta in prostate cancer. Mol Med 20:427-434

    Colciago A, Ruscica M, Mornati O, Piccolella M, Montagnani‑Marelli M, Eberini I, Festuccia C, Magni P, Motta M, Negri‑ Cesi P (2014) In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta‑adiol in AR‑positive RV1 cells. Biomed Res Int 2014:801473

    Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL (2002) Inhibition of androgen‑independent growth of prostate cancer xenografts by 17beta‑ estradiol. Clin Cancer Res 8:1003-1007

    Dey P, Jonsson P, Hartman J, Williams C, Strom A, Gustafsson JA (2012) Estrogen receptors beta1 and beta2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Mol Endocrinol 26:1991-2003

    Dey P, Strom A, Gustafsson JA (2014) Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene 33:4213-4225

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark